Results 151 to 160 of about 740 (167)
Some of the next articles are maybe not open access.

Avian paramyxovirus type 1 infections of racing pigeons: 4 laboratory assessment of vaccination

Veterinary Record, 1986
The immune response and protection from challenge afforded to adult pigeons by four different vaccination schedules were assessed. Intravenous challenge with a field pigeon isolate was done four weeks after the second of two doses of vaccine given four weeks apart. Little difference in protection was seen between two 0.25 ml and two 0.5 ml doses of oil
D J, Alexander, G, Parsons, R, Marshall
openaire   +2 more sources

Molecular characterization of two novel sub-sublineages of pigeon paramyxovirus type 1 in China

Archives of Virology, 2018
Pigeon paramyxovirus type 1 (PPMV-1) infection is enzootic in pigeon flocks and poses a potential risk to the poultry industry in China. To gain insight into the biological characteristics and transmission routes of circulating PPMV-1 in pigeons, 13 PPMV-1 isolates from domestic pigeons isolated during 2011-2015 in Guangxi province, China, were ...
Tianchao, Wei   +10 more
openaire   +2 more sources

Virological studies of paramyxovirus type 1 infection of pigeons.

The Canadian veterinary journal = La revue veterinaire canadienne, 2010
Over a period of three months in 1985, paramyxovirus type 1 infection was demonstrated for the first time in Canada, in six flocks of pigeons in Ontario, Alberta, and British Columbia. The paramyxovirus type 1 isolates did not cause clinical disease when serially passaged four times in four-to six-week-old chickens, and isolates were classified as ...
openaire   +1 more source

Undesirable reactions of domestic pigeons to vaccination against paramyxovirus type 1.

DTW. Deutsche tierarztliche Wochenschrift, 2004
Subcutaneous vaccination of fancy and racing pigeons with inactivated oil-based vaccines protects against all clinical manifestations caused by the Paramyxovirus type 1. Correct application of the vaccine may occasionally result in the development of granulomas or abscess-like lesions on the site of vaccine application.
B M, Bönner   +7 more
openaire   +1 more source

[Study on challenge dose of pigeon paramyxovirus type 1 (Chuansha strain)].

Bing du xue bao = Chinese journal of virology, 2014
In order to determine the challenge dose of pigeon paramyxovirus type 1 (PPMV-1) inactivated vaccine (S-1 strain). The virus titer of PPMV-1 E5 allantoic fluid (Chuansha strain) was determined using SPF chicken embryos in this research. After inoculating 30-day-old and 120-day-old pigeons with low-HI antibody against PPMV-1 (HI antibody < or =2) with ...
Jun-Ping, Zhang   +4 more
openaire   +1 more source

Evaluation of the pathogenicity of pigeon paramyxovirus type 1 isolated from racing pigeons

Journal of Comparative Pathology, 2019
B. Dolka   +3 more
openaire   +1 more source

Phylogenetic analysis and pathogenicity assessment of pigeon paramyxovirus type 1 circulating in China during 2007–2019

Transboundary and Emerging Diseases, 2022
Tiansong Zhan   +2 more
exaly  

Severe pigeon paramyxovirus 1 infection in a human case with probable post-COVID-19 condition

Emerging Microbes and Infections, 2023
Zhaomin Feng, Yanhui Chu, Chengli Que
exaly  

Home - About - Disclaimer - Privacy